Exploring the causal role of immune cells in cerebral aneurysm through single-cell transcriptomics and Mendelian randomization analysis
Clinical and Experimental Immunology · 2024
DOI: 10.1093/cei/uxae042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Yunhu Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Mendelian Randomization Analysis, Single-Cell Analysis, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cerebral aneurysm (CA) represents a significant clinical challenge, characterized by pathological dilation of cerebral arteries. Recent evidence underscores the crucial involvement of immune cells in CA pathogenesis. This study aims to explore the complex interplay between immune cells and CA formation. We analyzed single-cell RNA sequencing data from the GSE193533 dataset, focusing on unruptured CA and their controls. Comprehensive cell-type identification and pseudo-time trajectory analyses were conducted to delineate the dynamic shifts in immune cell populations. Additionally, a two-sample Mendelian randomization (MR) approach was employed to investigate the causal influence of various immunophenotypes on CA susceptibility and the reciprocal effect of CA formation on immune phenotypes. Single-cell transcriptomic analysis revealed a progressive loss of vascular smooth muscle cells (VSMCs) and an increase in monocytes/macrophages (Mo/MΦ) and other immune cells, signifying a shift from a structural to an inflammatory milieu in CA evolution. MR analysis identified some vital immunophenotypes, such as CD64 on CD14+ CD16+ monocytes (OR: 1.236, 95% CI: 1.064–1.435, P = 0.006), as potential risk factors for CA development, while others, like CD28– CD8br %CD8br (OR: 0.883, 95% CI: 0.789–0.988, P = 0.030), appeared protective. Reverse MR analysis demonstrated that CA formation could modulate specific immunophenotypic expressions, highlighting a complex bidirectional interaction between CA pathology and immune response. This study underscores the pivotal role of immune cells in this process through the integration of single-cell transcriptomics with MR analysis, offering a comprehensive perspective on CA pathogenesis, and potentially guiding future therapeutic strategies targeting specific immune pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
- Key Laboratory of Post-Neuroinjury Neuro-Repair and Regeneration in the Central Nervous System, Ministry of Education, Tianjin Medical University, Tianjin Key Laboratory of Injury and Regenerative Medicine of Nervous Sy…
- Department of Neurosurgery, the People's Hospital of HongHuaGang District of ZunYi, Zunyi, China.
ORCID-Profile: Shiao Tong, Tao Liu, Yunpeng Cai, Yuanmei Song, Hang Zhou, Rongcai Jiang
Zitieren
APA
Yu, Y., Tong, S., Liu, T., Cai, Y., Song, Y., Zhou, H., & Jiang, R. (2024). Exploring the causal role of immune cells in cerebral aneurysm through single-cell transcriptomics and Mendelian randomization analysis. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae042
Vancouver
Yu Y, Tong S, Liu T, Cai Y, Song Y, Zhou H, et al. Exploring the causal role of immune cells in cerebral aneurysm through single-cell transcriptomics and Mendelian randomization analysis. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxae042
BibTeX
@article{Yu2024,
author = {Yu, Yunhu and Tong, Shiao and Liu, Tao and Cai, Yunpeng and Song, Yuanmei and Zhou, Hang and Jiang, Rongcai},
title = {Exploring the causal role of immune cells in cerebral aneurysm through single-cell transcriptomics and Mendelian randomization analysis},
journal = {Clinical and Experimental Immunology},
year = {2024},
doi = {10.1093/cei/uxae042}
}
EUVIMED